Xvivo Perfusion
Clinical trials sponsored by Xvivo Perfusion, explained in plain language.
-
New device could save more hearts for transplant
Disease control OngoingThis study tests a new machine that keeps donor hearts healthy outside the body longer before transplant. It includes 141 adults with heart failure who need a new heart. The goal is to see if this method is safe and effective, potentially allowing more hearts from older or less i…
Phase: NA • Sponsor: XVIVO Perfusion • Aim: Disease control
Last updated May 26, 2026 07:29 UTC
-
New heart storage method could save more lives in transplants
Disease control OngoingThis study compares a new method of preserving donor hearts (non-ischemic preservation) to the standard cold storage method for heart transplants. The goal is to see if the new method leads to better heart function and fewer complications within the first month and year after tra…
Phase: NA • Sponsor: XVIVO Perfusion • Aim: Disease control
Last updated May 26, 2026 07:26 UTC
-
New machine could save more hearts for transplant
Disease control OngoingThis study tests a method to preserve hearts from donors after circulatory death using a machine that keeps them cool and oxygenated. The goal is to increase the number of hearts available for transplant. About 20 adults with heart failure who are already on the transplant list w…
Phase: NA • Sponsor: XVIVO Perfusion • Aim: Disease control
Last updated May 18, 2026 12:09 UTC
-
Lung transplant machine registry tracks Long-Term results
Knowledge-focused OngoingThis study collects information from people who receive donor lungs that were treated with a machine called the XVIVO Perfusion System. The machine keeps the lungs warm and breathing outside the body to check their health before transplant. The goal is to see how well the lungs w…
Sponsor: XVIVO Perfusion • Aim: Knowledge-focused
Last updated May 22, 2026 14:02 UTC